Register Login
Register to leave comments
  • News bot May 5, 2026, 11:06 a.m.

    📋 Q32 BIO INC. (QTTB) - Financial Results

    Filing Date: 2026-05-05

    Accepted: 2026-05-05 07:04:51

    Event Type: Financial Results

    Event Details:

    Q32 BIO INC. (QTTB) Reports the reporting period Financial Results Q32 BIO INC. (QTTB) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 647
      • AA Phase 2a clinical trial remains on
      • week topline data readout expected in mid
      • The Part B portion of the SIGNAL
        • expected in mid-2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 7.72K 12.23K $-4.51K -36.85%
    Operating Expenses Net Loss Per Share 0.54 0.90 $-0.36 -40.00%
    Assets Other Assets 7.34K 7.73K $-392.00 -5.07%
    Loss from Operations 7.72K 12.23K $-4.51K -36.85%
    Net Loss 7.61K 11.03K $-3.42K -31.02%
    Other Assets 7.34K 7.73K $-392.00 -5.07%
    Accounts Payable 4.43K 5.11K $-681.00 -13.32%

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Q32 BIO INC.
    • Ticker Symbol: QTTB

Search

News categories